A DDI Study to Assess the Effect of INC280 on the PK of Midazolam and Caffeine in Patients With cMET-dysregulated Advanced Solid Tumors
Clinical trial NCT02520752 · COMPLETED
Trial details
- NCT number
- NCT02520752
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-10
- Primary completion
- 2017-01-30
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.